Custom Lucite commemorative recognizing the first-in-human dose of a treatment for inflammatory lung diseases. (22ALJ326)
These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Custom Lucite commemorative recognizing the first-in-human dose of a treatment for inflammatory lung diseases. (22ALJ326)
Logo-themed crystal deal toy recognizing the recapitalization of Texas-based home health provider Frontpoint. (22AKL052)
Crystal financial tombstone marking the acquisition of Adapted Nutrition, which specializes in the keto supplements market. (21ALJ612)
Custom Lucite celebrating the approval by the U.S. Food and Drug Administration (FDA) of the drug Crenessity. Crenessity was developed by Neurocrine Biosciences to treat a rare congenital adrenal condition. (25ALJ020)
Custom crystal, incorporating a pharma vial design, celebrating the successful initial public offering on the Euronext Growth Oslo exchange of Oncoinvent. The Oslo-based company is focused on cancer treatments. (25LNL007)
Crystal deal tombstone, incorporating two logo cutouts, marking the acquisition of two Missouri-based manufacturers of surgical instruments. (22ALJ096)
Crystal deal tombstone celebrating Series A funding for Gather Heath, a Massachusetts-based primary care practice focused on older adults. (24AZH136)
Custom Lucite deal toy, replicating a spray bottle product, commemorating a follow-on stock offering by Novabay Pharmaceuticals. The Emeryville, California-based biopharmaceutical company develops products for the eye care market. (24AKL343)
Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
"*" indicates required fields
